Lorenzo Rocchini
Overview
Explore the profile of Lorenzo Rocchini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Serretta V, Scalici Gesolfo C, Di Maida F, Caruana G, Rocchini L, Moschini M, et al.
Urologia
. 2016 Aug;
83(3):145-148.
PMID: 27516352
Introduction: Prostatic Specific Antigen (PSA), Bacillus Calmette-Guerin (BCG) increase after intravesical BCG has been reported. The need of prostate biopsy in these patients is object of debate. The aim of...
12.
Moschini M, Karnes R, Suardi N, Bianchi M, Pellucchi F, Rocchini L, et al.
Clin Genitourin Cancer
. 2015 Sep;
14(3):e245-50.
PMID: 26382220
Background: The most common presenting symptom of bladder cancer (BCa) is hematuria. The present study was designed to define whether patients taking antiplatelet and/or anticoagulant drugs might experience hematuria at...
13.
Di Trapani E, Sanchez-Salas R, Gandaglia G, Rocchini L, Moschini M, Lizee D, et al.
World J Urol
. 2015 Jul;
34(2):207-13.
PMID: 26198750
Purpose: Despite the increasing number of studies confirming the importance of neoadjuvant chemotherapy (NC) in patients before radical cystectomy (RC) for bladder cancer (BCa), NC remains underused. The aim of...
14.
Pellucchi F, Freschi M, Moschini M, Rocchini L, Maccagnano C, Nazareno S, et al.
BJU Int
. 2015 Mar;
115(2):267-73.
PMID: 25756136
Objective: To compare the clinical reliability of the 1973 and 2004 World Health Organisation (WHO) classification systems in pT1 bladder cancer. Patients And Methods: We retrospectively evaluated 291 consecutive patients...
15.
Moschini M, Suardi N, Pellucchi F, Rocchini L, La Croce G, Capitanio U, et al.
Anticancer Res
. 2014 Jun;
34(6):3225-30.
PMID: 24922698
Aim: To investigate the impact of preoperative platelet count on pathological findings at the time of Radical Cystectomy for Bladder Cancer and postoperative cancer-specific and overall survival. Patients And Methods:...
16.
Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, et al.
Urol Int
. 2013 May;
91(1):1-9.
PMID: 23689345
Introduction: The ureteral involvement in deep pelvic endometriosis in usually asymptomatic and might lead to a silent loss of renal function. As a matter of fact, the diagnosis and the...
17.
Colombo R, Maccagnano C, Rocchini L, Pellucchi F
Urologia
. 2013 Apr;
80 Suppl 21:48-52.
PMID: 23559131
Despite the good quality of treatment expected with optimized transurethral resection (TUR) and adjuvant Bacillus Calmette-Guérin (BCG) regimen, many high-risk non-muscle invasive bladder cancer (NMIBC) patients recur and progress. According...
18.
Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, et al.
Eur Urol
. 2012 Oct;
63(1):e7-8.
PMID: 23092542
No abstract available.
19.
Salonia A, Castagna G, Sacca A, Ferrari M, Capitanio U, Castiglione F, et al.
J Sex Med
. 2012 Aug;
9(10):2708-15.
PMID: 22897643
Introduction: Erectile dysfunction (ED) has emerged progressively as a sentinel marker of cardiovascular disease (CVD). The correlation between ED and the burden arising from multiple comorbid conditions has been incompletely...
20.
Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, et al.
Urol Int
. 2012 Jul;
89(3):249-58.
PMID: 22813980
Background: The bladder is the most common affected site in urinary tract endometriosis, being diagnosed during gynecologic follow-up. The surgical urological treatment might lead to good results. Study Objective: To...